Asia Fernandez-Carvajal

My research is focused on ion channels and, particularly, on TRP channels to understand the molecular mechanism involved in the inflammatory sensitization processes and chronic pain. I have a proven track record in the evaluation of different aspects of the planning of screening and validation of targets, in drug discovery and in the design and automation of testing. I have registered 10 patents of new compounds, analgesics and cosmetics and I founded Antalgenics SL., a Spin-off biotechnological company focused on the development of novel molecules for topical treatment of skin pathologies by modulating the neurosensory system.